Search - tctmd.com

Displaying 21 - 40 of 60

Sort: Relevancy | Date

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation THT 2025

Time to Escalation: From the Golden Day to the Golden Six Hours

Presenter: Elric Zweck

February 11, 2025

Presentation THT 2025

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Presenter: Shelley Hall

February 11, 2025

Presentation THT 2025

Optimizing Outcomes in Cardiac Arrest and Shock

Presenter: Jacqueline Tamis-Holland

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Presenter: Matteo Pagnesi

February 11, 2025

Presentation THT 2025

Only Select Patients Should Have a PA Pressure Sensor

Presenter: Maria Rosa Costanzo

February 11, 2025

Presentation THT 2025

All NYHA III Patients Should Have a PA Pressure Sensor

Presenter: Michael Givertz

February 11, 2025

Presentation THT 2025

Preserving Access: Limiting the Use of Advanced Therapies

Presenter: Gerin Stevens

February 11, 2025

Presentation THT 2025

Increasing Access: Using Team-Based Care to Get STRONG

Presenter: Laura Cohen

February 11, 2025

Presentation THT 2025

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Presenter: Gad Cotter

February 11, 2025

Presentation THT 2025

Increasing Reach: Using TeleHealth to Get STRONGer

Presenter: Daniel Bensimhon

February 11, 2025

Presentation THT 2025

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Presenter: Nir Uriel

February 11, 2025

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Presenter: Mariell Jessup

March 05, 2024

Presentation THT 2024

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Presenter: Harriette G.C. Van Spall

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Advertisement

Harnessing Real World Data to Test Emerging Technologies

Time to Escalation: From the Golden Day to the Golden Six Hours

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Optimizing Outcomes in Cardiac Arrest and Shock

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Only Select Patients Should Have a PA Pressure Sensor

All NYHA III Patients Should Have a PA Pressure Sensor

Preserving Access: Limiting the Use of Advanced Therapies

Increasing Access: Using Team-Based Care to Get STRONG

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Increasing Reach: Using TeleHealth to Get STRONGer

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Debating the Role of T-TEER in the Sickest Patients

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content